# OpenAI seeks role in drafting AI drug rules while selling the tech those rules would govern - Date: 2026-04-16 - Category: Artificial Intelligence OpenAI is inside the FDA rulemaking process with formal comments, while selling the same AI technology to Novo Nordisk across research, manufacturing, and commercial ops. Smaller biotechs were not at the table. ---